BCAX
Bicara Therapeutics
BCAX
BCAX
92 hedge funds and large institutions have $633M invested in Bicara Therapeutics in 2025 Q1 according to their latest regulatory filings, with 28 funds opening new positions, 26 increasing their positions, 18 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
14% less funds holding in top 10
Funds holding in top 10: 7 → 6 (-1)
22% less capital invested
Capital invested by funds: $814M → $633M (-$180M)
50% less call options, than puts
Call options by funds: $1K | Put options by funds: $2K
Holders
92
Holding in Top 10
6
Calls
$1K
Puts
$2K
Top Buyers
| 1 | +$26.8M | |
| 2 | +$19.5M | |
| 3 | +$9.76M | |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
+$8.3M |
| 5 |
Janus Henderson Group
London,
United Kingdom
|
+$6.43M |
Top Sellers
| 1 | -$31.3M | |
| 2 | -$14.3M | |
| 3 | -$12.9M | |
| 4 |
FFM
Fairmount Funds Management
West Conshohocken,
Pennsylvania
|
-$6.51M |
| 5 |
FTM
First Turn Management
Del Mar,
California
|
-$6.03M |
